Dr David Kadmon, MD | |
132 Old River Rd, Suite B-2, Lincoln, RI 02865-1161 | |
(401) 333-2784 | |
Not Available |
Full Name | Dr David Kadmon |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 132 Old River Rd, Lincoln, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912946658 | NPI | - | NPPES |
4112 | Other | RI | NHPRI |
154359 | Other | RI | TUFTS |
0000027970 | Other | RI | BC/BS OF RI |
401541 | Other | RI | BLUECHIP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MD09598 (Rhode Island) | Primary |
174400000X | Specialist | MD109667 (Rhode Island) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr David Kadmon, MD Po Box 9244, Providence, RI 02940-9244 Ph: () - | Dr David Kadmon, MD 132 Old River Rd, Suite B-2, Lincoln, RI 02865-1161 Ph: (401) 333-2784 |
News Archive
Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization Application (MAA) for SB2, its Remicade (Infliximab) biosimilar candidate, has been submitted to the European Medicines Agency (EMA).
Brain changes after stroke may lead to increase in alcohol-seeking behavior, at least in animal models, according to research published Wednesday in the journal Scientific Reports.
Genome wide association studies (GWAS) scan the entire genome in order to pinpoint genetic variants associated with a particular disease. The technique is employed to identify biological pathways - the series of actions and changes that have occurred in cells and genetic material - that can be linked to the causation of a disease.
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
› Verified 5 days ago
Dr. Andrew Thomas Thorp Jr., MD, MBA Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Blackstone Valley Pl, Lincoln, RI 02865 Phone: 401-762-3838 Fax: 401-762-8252 | |
Robert H Cohen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Commerce St, Internal Medicine, Lincoln, RI 02865 Phone: 401-793-8500 Fax: 401-793-8511 | |
Dr. Christopher J Superczynski, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 652 George Washington Hwy Unit 201, Lincoln, RI 02865 Phone: 401-353-5224 Fax: 401-353-5162 | |
Frank Michael D'alessandro, MD INC Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2 Wake Robin Rd, Lincoln, RI 02865 Phone: 401-334-3105 | |
Richard Vannieuwenhuize, M.D. Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 6 Blackstone Valley Pl Ste 305, Lincoln, RI 02865 Phone: 401-334-1097 Fax: 401-305-5497 | |
Michelle C. Vannieuwenhuize, M.D. Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 6 Blackstone Valley Pl, Building #3 Suite 305, Lincoln, RI 02865 Phone: 401-334-1097 Fax: 401-305-5497 | |
Karen Diane Grande, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2 Wake Robin Rd, Lincoln, RI 02865 Phone: 401-333-9595 Fax: 401-334-9595 |